The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
NCT03014401
Summary
The purpose of this study is to compare the clinical and functional outcomes of patients with mild to moderate arthroscopically confirmed osteoarthritis between the following two groups: 1. Partial fat pad harvest with Adipose-Derived Stem Cell (ADSC) transplantation with standard arthroscopic treatment consisting of: partial meniscectomy, cartilage stabilization, loose body removal and selective synovectomy. 2. Standard arthroscopic treatment (above) without cell transplant.
Eligibility
Inclusion Criteria: * Age between 35 and 70 years-old * Patient is scheduled to undergo one or a combination of the following procedures: * Meniscal debridement or partial menisectomy * Meniscal repair that does not necessitate a different postoperative protocol from meniscal debridement or partial menisectomy * Removal of loose bodies * Chondroplasty * Synovectomy * Soft tissue releases for flexion or extension contracture. * Diagnosis of pre-existing mild to moderate osteoarthritis of the medial or lateral femoral condyle (Kellgren-Lawrence Grade 2 or 3) * \< 6 months of knee pain or \< 6 months of a significant exacerbation of existing knee pain * Physical examination findings consistent with the proposed surgical procedure. * Failure of conservative therapy consisting of a minimum of 6 weeks of physical therapy and trial of anti-inflammatory medications, with or without concomitant bracing and/or injections Exclusion Criteria: * Age \< 35 or \> 70 years old * Radiographs demonstrating either no, little or severe osteoarthritis (Kellgren-Lawrence Grade 0, 1 or 4) * Previous injury or surgery to the infrapatellar fat pad (assessed by MRI) * Patient scheduled to undergo any concomitant surgical procedures with the exception of: * Meniscal debridement or partial menisectomy * Meniscal repair that does not necessitate a different postoperative protocol from meniscal debridement or partial menisectomy * Removal of loose bodies * Chondroplasty * Synovectomy * Soft tissue releases for flexion or extension contracture * Prior surgery on ipsilateral knee involving cartilage regeneration (microfracture, Autologous Chondrocyte Implantation, etc) or meniscal transplant/implant * Previous arthroscopy within 1 year * Subchondral edema
Conditions2
Locations3 sites
California
2 sitesColorado
1 siteBrowse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT03014401